NuVasive (NASDAQ:NUVA) expects Q4 revenue of ~$310M vs a consensus of $304.31M.
Q4 highlights: NUVA expects U.S. Spinal Hardware revenue increased ~8%; U.S. Surgical Support revenue increased ~3% and International revenue increased ~14% on a reported and constant currency basis.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.